Skip to main content
. Author manuscript; available in PMC: 2014 Jun 5.
Published in final edited form as: Leuk Lymphoma. 2010 Jun;51(6):1015–1019. doi: 10.3109/10428191003721342

Table I.

Characteristics of patients treated with single agent lenalidomide.

Characteristic Number (%)
Median age (years) 70
    Range (46–84)
Gender
    Male 10 (59%)
Heavy chain
    IgG 10 (59%)
    IgA 5 (29%)
    Light chain only 2 (12%)
Light chain
    Lambda 10 (59%)
Durie–Salmon stage
    IIA 4 (24%)
    IIIA 13 (76%)
International staging system
    I 11 (65%)
    II 6 (35%)
    III 2 (12%)
β2-Microglobulin (mg/L)
    Median (range) 2.84 (2.13–10.7)
    Patients with β2-microglobulin >5.5 mg/L 1 (5%)
Hemoglobin (g/dL)
    Median (range) 11.6 (8.2–15.8)
    Patients with hemoglobin < 10 g/dL 2 (11%)
Cytogenetics
    Deletion 13q 4 (24%)
    Deletion 17p 1 (6%)
    Not available 10 (59%)
Lytic bone disease 11 (65%)